High-risk human papillomavirus testing in first-void urine as a novel and non-invasive cervical cancer screening modality—a Danish diagnostic test accuracy study

Abstract Background First-void urine (FVU) collection for high-risk human papillomavirus (hrHPV) testing has game-changing potential to improve cervical cancer prevention among under-screened women who remain unreached by clinician-based cervical cancer screening and vaginal self-sampling. Yet, the...

Description complète

Détails bibliographiques

Auteurs principaux:	Mette Tranberg, Severien Van Keer, Jørgen Skov Jensen, Pia Nørgaard, Line Winther Gustafson, Anne Hammer, Pinar Bor, Karen Omann Binderup, Christina Blach, Alex Vorsters
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2025-06-01
Collection:	BMC Medicine
Sujets:	Cervical cancer screening Mass screening HrHPV DNA testing Urinary hrHPV testing Uterine cervical dysplasia Sensitivity and specificity
Accès en ligne:	https://doi.org/10.1186/s12916-025-04149-0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!